Complement inhibitors finally find orphan niches.
Ratner
Mark
M
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003169:Complement Inactivator Proteins / Q000008:administration & dosage*; D017277:Drug Approval; D015195:Drug Design; D009965:Orphan Drug Production; D014481:United States
D000911:Antibodies, Monoclonal; D003169:Complement Inactivator Proteins